Celltrion
068270.KS
#802
Rank
$24.48 B
Marketcap
$118.23
Share price
-0.60%
Change (1 day)
-1.98%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $2.26 Billion USD

According to Celltrion 's latest financial reports the company's total liabilities are $2.26 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celltrion - Total liabilities on balance sheet (from 2007 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31$1.28 B-6%
2021-12-31$1.36 B-6.91%
2020-12-31$1.46 B71.78%
2019-12-31$0.85 B4.92%
2018-12-31$0.81 B-1.88%
2017-12-31$0.82 B21.4%
2016-12-31$0.68 B-14.48%
2015-12-31$0.79 B-10.28%
2014-12-31$0.88 B5.24%
2013-12-31$0.84 B28.55%
2012-12-31$0.65 B50.18%
2011-12-31$0.43 B31.43%
2010-12-31$0.33 B40.23%
2009-12-31$0.23 B5.59%
2008-12-31$0.22 B497.84%
2007-12-31$37.64 M